| Views | |
|---|---|
| Development of a transcutaneous form of desloratadine | 65 |
| August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | |
|---|---|---|---|---|---|---|---|
| Development of a transcutaneous form of desloratadine | 0 | 8 | 12 | 3 | 0 | 2 | 8 |
| Views | |
|---|---|
| Ageev_Development_24.pdf | 50 |
| Views | |
|---|---|
| United States | 21 |
| Canada | 7 |
| China | 4 |
| EU | 3 |
| India | 3 |
| Germany | 2 |
| Russia | 2 |
| Australia | 1 |
| Brazil | 1 |
| Denmark | 1 |
| Views | |
|---|---|
| Mountain View | 9 |
| Ottawa | 7 |
| Beijing | 3 |
| Dearborn | 3 |
| Mumbai | 3 |
| Sacramento | 3 |
| Palo Alto | 2 |
| Amman | 1 |
| Englewood | 1 |
| Haugesund | 1 |